Evidence map›Paper›PMID 32678875›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2021

The CARMA Study: Early Infant Antiretroviral Therapy-Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later.

Caroline Foster, Sara Domínguez-Rodríguez, Alfredo Tagarro, Triantafylia Gkouleli, Judith Heaney, Sarah Watters, Alasdair Bamford, Katy Fidler, Marisa Navarro, Anita De Rossi and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.5field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Accelerated CD8iScience · 2024
    Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Caroline FosterImperial College Healthcare NHS Trust, London, United Kingdom.
Sara Domínguez-RodríguezPediatric Infectious Diseases Unit, Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.
Alfredo TagarroPediatric Infectious Diseases Unit, Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.
Triantafylia GkouleliDepartment of Population, Policy and Practice, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Judith HeaneyDepartment of Population, Policy and Practice, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Sarah WattersDepartment of Population, Policy and Practice, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Alasdair BamfordGreat Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
Katy FidlerBrighton and Sussex Medical School, Falmer, United Kingdom.
Marisa NavarroPediatric Infectious Disease Unit, Institute of Investigation, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Anita De RossiDepartment of Surgery, Oncology and Gastroenterology, Section of Oncology and Immunology, University of Padova, Padova, Italy.
Paolo PalmaDivision of Immune and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesu, Rome, Italy.
Eleni NastouliDepartment of Population, Policy and Practice, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Paolo RossiDivision of Immune and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesu, Rome, Italy.
Carlo GiaquintoDepartment of Surgery, Oncology and Gastroenterology, Section of Oncology and Immunology, University of Padova, Padova, Italy.
Pablo RojoPediatric Infectious Diseases Unit, Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.
Great Ormond Street Hospital · GBBambino Gesù Children's Hospital · ITUniversity of Padua · ITBrighton and Sussex Medical School · GBHospital General Universitario Gregorio Marañón · ESImperial College Healthcare NHS Trust · GBUniversity College London Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStrategies aimed at antiretroviral therapy (ART)-free remission will target individuals with a limited viral reservoir. We investigated factors associated with low reservoir measured as total human immunodeficiency virus type 1 (HIV-1) DNA in peripheral blood mononuclear cells (PBMCs) in perinatal infection (PaHIV).

methodsChildren from 7 European centers in the Early Treated Perinatally HIV Infected Individuals: Improving Children's Actual Life (EPIICAL) consortium who commenced ART aged <2 years, and remained suppressed (viral load [VL] <50 copies/mL) for >5 years were included. Total HIV-1 DNA was measured by quantitative polymerase chain reaction per million PBMCs. Factors associated with total HIV-1 DNA were analyzed using generalized additive models. Age, VL at ART initiation, and baseline CD4% effects were tested including smoothing splines to test nonlinear association.

resultsForty PaHIV, 27 (67.5%) female 21 (52.5%) Black/Black African, had total HIV-1 DNA measured; median 12 (IQR, 7.3-15.4) years after ART initiation. Eleven had total HIV-1 DNA <10 copies/106 PBMCs. HIV-1 DNA levels were positively associated with age and VL at ART initiation, baseline CD4%, and Western blot antibody score. Age at ART initiation presented a linear association (coefficient = 0.10 ± 0.001, P ≤ .001), the effect of VL (coefficient = 0.35 ± 0.1, P ≤ .001) noticeable >6 logs. The effect of CD4% (coefficient = 0.03 ± 0.01, P = .049) was not maintained >40%.

conclusionsIn this PaHIV cohort, reduced total HIV-1 DNA levels were associated with younger age and lower VL at ART initiation. The impact of early-infant treatment on reservoir size persists after a decade of suppressive therapy.

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsDNA, ViralFemaleHumansInfantLeukocytes, MononuclearViral LoadAnti-HIV AgentsDNA, Viraladolescentschildrenearly treatedHIV-1HIV reservoirviral suppression

Identifiers

PMID32678875
PMCPMC8023306
OpenAlexW3042622121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.